UK-based Pathios Therapeutics raises €23.4 million Series B to advance first-in-class immunotherapy approach

Published on April 18, 2024

Pathios Therapeutics, a biotech company focused on the development of first-in-class therapies for cancer, today announced that the company has raised €23.4 million in the first close of a Series B financing. The financing consists of a new strategic investment from Bristol Myers Squibb, as well as support from existing investors including Canaan and Brandon…

This content is for members only. Visit the site and log in/register to read.

The post UK-based Pathios Therapeutics raises €23.4 million Series B to advance first-in-class immunotherapy approach appeared first on EU-Startups.

Continue reading on website
Other news

Lemon a Manchester-based fintech secured over €580K pre-seed to help grow its business.

April 18, 2024
Manchester-based fintech, Lemon, is announcing it has successfully raised its pre-seed funding round, securing over €580K to support the business through the next stage of development. Led by SFC Capital, the UK’s most active early-stage VC, and Pitchdrive, a European fund specialising in pre-seed and seed investment, this backing offers more than monetary value, as… This content is for members on

London-based FilmChain raises €2.8 million to bring automation to payments in film and TV

April 18, 2024
UK-based FilmChain, co-founded by Maria Tanjala and Irina Albita, has secured a €2.8 million investment. This financial milestone was achieved through a round led by the Holt IntersXion fund, with support from Roca X, DeBa Ventures, TechAngels Romania, and returning investor HearstLab. The investment, which also converts previous notes, signals a robust vote of confidence… This content is for memb